Morning Watch List: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Rite Aid Corporation (NYSE:RAD), KeyCorp. (NYSE:KEY), MannKind Corp. (NASDAQ:MNKD),

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) announced that the Psychopharmacologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) will review data included in ACADIA’s New Drug Application (NDA) for NUPLAZID™ (pimavanserin) for the treatment of psychosis associated with Parkinson’s disease. The Advisory Committee Meeting is scheduled for March 29, 2016.

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) belongs to Healthcare sector. Its weekly performance is -5.21%. On last trading day company shares ended up at $18.73. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) distance from 50-day simple moving average (SMA50) is -6.20%.

Rite Aid Corporation (NYSE:RAD) said that, its Foundation’s Big Hearts awarded two checks totaling $12,500 to the Wyoming Valley Children’s Association and the Children’s Service Center of Wyoming Valley.

Rite Aid Corporation (NYSE:RAD) shares remains unchanged in last trading session and ended the day at $7.96. RAD Gross Margin is 26.40% and its return on assets is 18.00%. Rite Aid Corporation (NYSE:RAD) quarterly performance is 1.02%.

KeyCorp. (NYSE:KEY) announced that Don Kimble, Chief Financial Officer, andChris Gorman, President of Key Corporate Bank, will present at the RBC Capital Markets Financial Institutions Conference in New York City on Tuesday, March 8, 2016, at 8:30 a.m. ET.

KeyCorp. (NYSE:KEY) belongs to Financial sector. Its net profit margin is 34.10% and weekly performance is 0.19%. On last trading day company shares ended up at $10.72. KeyCorp. (NYSE:KEY) distance from 50-day simple moving average (SMA50) is -8.31%.

MannKind Corp. (NASDAQ:MNKD) announced that it has withdrawn its offer to employ Duane M. DeSisto as its President and Chief Executive Officer as a consequence of objections raised by Insulet Corp., the former employer of DeSisto, that the employment of DeSisto by MannKind would violate Insulet’s non-competition agreement with DeSisto, which is in effect until Sept. 17, 2016.

MannKind Corp. (NASDAQ:MNKD) shares fell -4.63% in last trading session and ended the day at $1.03. MNKD return on assets is -36.90%. MannKind Corp. (NASDAQ:MNKD) quarterly performance is -53.18%.

MetLife, Inc. (NYSE:MET) announced that it will hold an investor conference on Thursday, Sept. 29, 2016, in New York City. Presenters will include members of MetLife’s senior management team.

On 26 February, MetLife, Inc. (NYSE:MET) shares moved up 1.70% and was closed at $40.09. MET EPS growth in last 5 year was 10.30%. MetLife, Inc. (NYSE:MET) year to date (YTD) performance is -16.11%.

Leave a Reply

Your email address will not be published. Required fields are marked *